Article Text

PDF

Review: a short course of antibiotic treatment is as effective as a standard course in children with urinary tract infection
  1. James Larcombe, MBChB,
  2. Dip Adv, GP, FRCGP
  1. Centre for Integrated Health Care Research
 Durham, UK

    Statistics from Altmetric.com

    
 
 QUESTION: In children with urinary tract infection (UTI), what is the effectiveness of short course (2−4 d) compared with standard duration (7–14 d) of antibiotic treatment?

    Data sources

    Studies in all languages were identified by searching Medline (1966 to February 2001), EMBASE/Excerpta Medica (1988 to February 2001), the Cochrane Library (Issue 1, 2001), bibliographies of relevant studies and textbooks, and conference abstracts.

    Study selection

    Studies were selected if they were randomised controlled trials (RCTs) or quasi RCTs, involved children aged 3 months to 18 years with culture proven symptomatic UTI, and compared a short course (2–4 d) with a standard duration (7–14 d) of antibiotic treatment. Only studies that used the same antibiotic in both the short and standard duration arms were included.

    Data extraction

    Data were extracted on participant characteristics and numbers, antibiotics used, study duration and quality, and outcomes.

    Main results

    10 RCTs (652 children) were included. The meta-analysis (random effects model) showed that short duration of antibiotic treatment did not differ from standard duration for frequency of bacteriuria (colony counts ≥105 organisms/ml of urine) at 0–7 days after completing treatment, recurrent UTI at 10 days to 15 months after completing treatment, or recurrent UTI caused by resistant organisms ≥10 days after completing treatment (table).

    Short (2–4 d) v standard (7–14 d) duration of antibiotic treatment in children with urinary tract infection (UTI)*

    Conclusion

    In children with urinary tract infection, a short course (2–4 d) of antibiotic treatment is as effective as a standard course (7–14 d).

    Commentary

    The standard treatment for UTI in children is ≥7 days of an appropriate antibiotic. In women (but not in men), 3 day courses are advocated for cystitis, with longer courses reserved for ascending infection.1 The reasons suggested for longer courses in children include (1) underlying urinary tract abnormality commonly presents with infection, (2) irreversible renal damage may occur in susceptible children, and (3) diagnosis is difficult in younger children.

    5 systematic reviews have compared standard with short courses of antibiotics for UTI in children. They show a range of conclusions, perhaps reflecting their inclusion criteria rather than other differences.

    The review of Michael et al most favours a shorter course treatment. Michael et al excluded comparisons with single day or single dose regimens. Subanalysis in 2 reviews2–3 suggested that very short courses might be therapeutically inferior. This review also excluded RCTs using different antibiotics in treatment and control arms. However, the review itself found no influence of specific antibiotics on outcomes.

    The authors add several cautionary notes to their conclusion of no difference between short and standard courses. Firstly, there are wide confidence intervals. Secondly, all studies excluded children with pyelonephritis and known urinary tract pathology. Thirdly, 2 studies (1 of which was a large contributor to the meta-analysis) included children with asymptomatic bacteriuria, who may be harmed by treatment. Fourthly, all studies included children with recurrent UTI, who have higher rates of treatment failure. The authors estimate the risk of treatment failure in unselected populations (eg, in primary care populations) as between −1.1% and 2.3%, and in selected populations (ie, typical of participants) as between −5% and 11%. Therefore, what should clinicians do?

    Choosing treatment length is probably secondary to identifying the very few high risk patients presenting with their first UTI. Thus, despite the scientific quality of this review, its effect may be restricted to the management of the older child (in whom clinical markers are more reliable), and to children known to be at minimal risk of complications.

    References

    View Abstract

    Footnotes

    • For correspondence: Dr E Hodson, The Children’s Hospital at Westmead, Westmead, New South Wales, Australia. Elisah{at}chw.edu.au

    • Source of funding: no external funding.

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.